Literature DB >> 20801762

Abnormal axial diffusivity in the deep gray nuclei and dorsal brain stem in infantile spasm treated with vigabatrin.

G N Simao1, S Zarei Mahmoodabadi, O C Snead, C Go, E Widjaja.   

Abstract

We evaluated the DTI changes in the deep gray nuclei and dorsal brain stem, which demonstrated abnormal T2 and/or diffusion signal intensity, in 6 patients with infantile spasm treated with vigabatrin compared with 6 age-matched controls. Regions of interest were placed in the globi pallidi, thalami, and dorsal brain stem; FA, trace, D(‖), and D(⊥) were measured. Patients on vigabatrin had significantly lower FA in both globi pallidi (P = .01) and the dorsal brain stem (P < .01), significantly lower trace in both globi pallidi (P = .01) and the thalami (P = .02 and .01 for right and left, respectively), and significantly lower D(‖) in both globi pallidi (P ≤ .01), the thalami (P < .01), and the dorsal brain stem (P = .03). There were no significant differences in D(⊥) of the globi pallidi, thalami, or dorsal brain stem in patients compared with controls. The findings suggest that axonal changes play a greater role in the observed abnormal signal intensity, with lesser contribution from myelin changes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801762      PMCID: PMC7964948          DOI: 10.3174/ajnr.A2224

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  17 in total

1.  Changes in water diffusion due to Wallerian degeneration in peripheral nerve.

Authors:  C Beaulieu; M D Does; R E Snyder; P S Allen
Journal:  Magn Reson Med       Date:  1996-10       Impact factor: 4.668

2.  Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms.

Authors:  Aphrodite Dracopoulos; Elysa Widjaja; Charles Raybaud; Carol A Westall; O Carter Snead
Journal:  Epilepsia       Date:  2010-04-02       Impact factor: 5.864

3.  Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.

Authors:  R S Sidhu; M R Del Bigio; U I Tuor; S S Seshia
Journal:  Exp Neurol       Date:  1997-04       Impact factor: 5.330

4.  Pathological evidence of vacuolar myelinopathy in a child following vigabatrin administration.

Authors:  Myles Horton; Mubeen Rafay; Marc R Del Bigio
Journal:  J Child Neurol       Date:  2009-09-22       Impact factor: 1.987

5.  Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy.

Authors:  James W Wheless; Lionel Carmant; Martina Bebin; Joan A Conry; Catherine Chiron; Roy D Elterman; Michael Frost; Juliann M Paolicchi; W Donald Shields; Elizabeth A Thiele; Mary L Zupanc; Stephen D Collins
Journal:  Epilepsia       Date:  2008-11-17       Impact factor: 5.864

6.  Diffusion tensor imaging detects early Wallerian degeneration of the pyramidal tract after ischemic stroke.

Authors:  Götz Thomalla; Volkmar Glauche; Martin A Koch; Christian Beaulieu; Cornelius Weiller; Joachim Röther
Journal:  Neuroimage       Date:  2004-08       Impact factor: 6.556

7.  Vigabatrin-induced lesions in the rat brain demonstrated by quantitative magnetic resonance imaging.

Authors:  G D Jackson; S R Williams; R O Weller; N van Bruggen; N E Preece; S C Williams; W H Butler; J S Duncan
Journal:  Epilepsy Res       Date:  1994-05       Impact factor: 3.045

8.  Effects of vigabatrin and of GABA on myelinated rat cerebellar cultures: preliminary data.

Authors:  J J Hauw; J M Boutry; P Sun; V Sazdovitch; C Duyckaerts
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

9.  Transient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrin.

Authors:  Mathieu Milh; Nathalie Villeneuve; Fréderique Chapon; Sandrine Pineau; Sylvie Lamoureux; Marie-Odile Livet; Céline Bartoli; Catherine Hugonenq; Josette Mancini; Brigitte Chabrol; Nadine Girard
Journal:  J Child Neurol       Date:  2009-03       Impact factor: 1.987

10.  Use of ex vivo magnetic resonance imaging to detect onset of vigabatrin-induced intramyelinic edema in canine brain.

Authors:  R G Peyster; N M Sussman; B L Hershey; W E Heydorn; L R Meyerson; J T Yarrington; J P Gibson
Journal:  Epilepsia       Date:  1995-01       Impact factor: 5.864

View more
  6 in total

1.  Reversible MRI Changes in an Infant with Epileptic Spasms on Low Dose Vigabatrin.

Authors:  Puneet Jain; Raman Alwadhi; Vikash Kumar
Journal:  Indian J Pediatr       Date:  2016-01-28       Impact factor: 1.967

2.  T2 hyperintense signal of the central tegmental tracts in children: disease or normal maturational process?

Authors:  Sergio Aguilera-Albesa; Andrea Poretti; Dagmar Honnef; Meral Aktas; Maria Eugenia Yoldi-Petri; Thierry A G M Huisman; Martin Häusler
Journal:  Neuroradiology       Date:  2012-01-21       Impact factor: 2.804

3.  Whole genome sequencing identifies SCN2A mutation in monozygotic twins with Ohtahara syndrome and unique neuropathologic findings.

Authors:  Marlin Touma; Mugdha Joshi; Meghan C Connolly; P Ellen Grant; Anne R Hansen; Omar Khwaja; Gerard T Berry; Hannah C Kinney; Annapurna Poduri; Pankaj B Agrawal
Journal:  Epilepsia       Date:  2013-03-28       Impact factor: 5.864

4.  Partial correlation analyses of global diffusion tensor imaging-derived metrics in glioblastoma multiforme: Pilot study.

Authors:  David Cortez-Conradis; Camilo Rios; Sergio Moreno-Jimenez; Ernesto Roldan-Valadez
Journal:  World J Radiol       Date:  2015-11-28

5.  Cerebral diffusion tensor MR tractography in tuberous sclerosis complex: correlation with neurologic severity and tract-based spatial statistical analysis.

Authors:  A M Wong; H-S Wang; E S Schwartz; C-H Toh; R A Zimmerman; P-L Liu; Y-M Wu; S-H Ng; J-J Wang
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-11       Impact factor: 3.825

6.  In-vivo multi-exponential T2, magnetization transfer and quantitative histology in a rat model of intramyelinic edema.

Authors:  Kevin D Harkins; William M Valentine; Daniel F Gochberg; Mark D Does
Journal:  Neuroimage Clin       Date:  2013-06-22       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.